Written on December 10, 2008 – 10:46 am | by Maria Mihale |


The technological progress does, indeed, show everyone how far the human mind can go, but without the controversies raised concerning the implications of all sorts of inventions that have seen the light of the day in the past years, neither the excitement, nor the passions that give birth to great ideas wouldn’t exist. No one knows, for example, what effects do cell phones have on regular users. Actually, it isn’t clear whether these consequences are real or not, but there’s no doubt about the fact that several groups of conservative people had “violent” reactions concerning the high cell phone radiation levels that affect their health.

Omega Pharma is a Belgian-based company that distributes health products and that came up with a solution for those who tend to excessively use the mobile phone. They’ve just announced a brand new product, more precisely a chip that is said to be able to counter “potentially damaging radiation” emerged from mobile phones. Putting all of their hopes in the E-waves phone chip, the company says that while testing it they discovered that it actually decreased symptoms like headaches or loss of concentration that can be connected with the use of mobile phones.



The chip will be commercially tested starting today, and it can be purchased for 38.95 euros (meaning $50.1). There are only 30,000 chips available on day one, but the company promises to continue the production for foreign markets if needed. “If we need 10 million, then we’ll go for that”, said Chief Executive Marc Coucke. Rumors say that Omega will begin shipping the chip in other countries (besides Belgium) starting the first months of the next year. In addition, three similar devices will complete a line of chips meant to keep track of the cell phone radiation levels: one for the car use, one for the computer and one in the home.

The only bad thing is that the chip is more expensive than many of the cell phones available in the market. And who would be willing to spend twice the money on something that prevents uncertain risks?

(Source: Reuters)